Skip to content

A single-center study to compare the efficacy of different interventions in reducing the weight of Chinese obese patients

A single-center study to compare the efficacy of different interventions in reducing the weight of Chinese obesity patients

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR1800015923
Enrollment
Unknown
Registered
2018-04-29
Start date
2018-06-01
Completion date
Unknown
Last updated
2018-04-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

simple obesity

Interventions

Diet group:lifestyle modification+ketogenic diet
Benaglutide group:lifestyle modification+Benaglutide
Respirtator group:lifestyle modification+continuous positive airway pressure treatment

Sponsors

Nanjing Medical University affiliated Wuxi People's Hospital
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 60 Years

Inclusion criteria

Inclusion criteria: 1. simple obese patients with a BMI=30kg/m^2 or a BMI=28 kg/m^2 combined with hyperlipidemia,high blood pressure,sleep apnea or abnormal glucose tolerance; 2. aged 18-60 years old, male or female; 3. Patients can understand and sign the informed consent; 4. Women in childbearing age agree to use contraceptive measures during the test.

Exclusion criteria

Exclusion criteria: 1. existed diabetes or diabetes diagnosed in the screening stage; 2. severe infection,severe injuries, severe and acute cardiovascular and cerebrovascular diseases,or in operation period; 3. serum TG level more than 11.3 mmol/L; 4. a history of malignancy; 5. a history of psychiatric illnes or neurological diseases; 6. combined with rheumatic and immune diseases; 7. female during pregnancy or lactation; 8. participate in other clinical trials within three months; 9. unable, unwilling or unwilling to comply with the research requirements, including lifestyle modification, return visit, dose description and subject responsibility; 10. secondary obesity(such as Cushing's syndrome, hypothyroidism); 11. long-term use of drugs that lead to obesity(such as glucocorticoids); 12. usage of weight-loss drugs (including GLP-1 receptor agonist) or a history of bariatric surgery within three months; 13. a history or a family history of thyroid medullary carcinoma (MTC),or type 2 multiple endocrine adenoma syndrome(MEN); 14. a history of pancreatitis.

Design outcomes

Primary

MeasureTime frame
Weight;

Secondary

MeasureTime frame
Height;Waist circumference;Hip circumference;Neck circumference;Calf circumference;Thigh circumference;Heart rate;Blood pressure;Blood sugar;Blood lipid;Microalbuminuria;Visceral fat;

Countries

China

Contacts

Public ContactXu Lan

Nanjing Medical University affiliated Wuxi People's Hospital

xulan126@126.com+86 13358111966

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026